miR-1-5p targets TGF-βR1 and is suppressed in the hypertrophying hearts of rats with pulmonary arterial hypertension

• Martin Connolly,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Molecular Medicine, National Heart & Lung Institute, Imperial College London, London, United Kingdom

  http://orcid.org/0000-0002-6156-8244

  ⨯
• Benjamin E. Garfield,

  Roles Data curation, Methodology

  Affiliations Molecular Medicine, National Heart & Lung Institute, Imperial College London, London, United Kingdom, National Pulmonary Hypertension Centre at the Royal Brompton and Harefield NHS Trust and National Heart and Lung Institute, Imperial College London, London, United Kingdom

  ⨯
• Alexi Crosby,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Nick W. Morrell,

  Roles Project administration, Supervision, Writing – review & editing

  Affiliation Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Stephen J. Wort,

  Roles Conceptualization, Funding acquisition, Writing – review & editing

  Affiliation National Pulmonary Hypertension Centre at the Royal Brompton and Harefield NHS Trust and National Heart and Lung Institute, Imperial College London, London, United Kingdom

  ⨯
• Paul R. Kemp

  Roles Conceptualization, Formal analysis, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: p.kemp@imperial.ac.uk

  Affiliation Molecular Medicine, National Heart & Lung Institute, Imperial College London, London, United Kingdom

  ⨯